UHRF1 and malignant colon neoplasm: Recent study indicates that UHRF1 acts as an oncogene by silencing 8 selected TSGs in colon cancer cells through promoter hypermethylation of these TSGs and correlated with poor prognosis and the shortened overall survival rates (Kong et al. 2019).